Featured Research

from universities, journals, and other organizations

Vision-Saving Treatment Effective For Patients With Eye Cancer

Date:
July 17, 2001
Source:
Ohio State University
Summary:
Patients suffering from a certain form of cancer of the eye may not need to have their diseased eye removed, based on a new study.

COLUMBUS, Ohio - Patients suffering from a certain form of cancer of the eye may not need to have their diseased eye removed, based on a new study.

The results of the Collaborative Ocular Melanoma Study (COMS), a multi-center trial released today (July 12) by the Archives of Ophthalmology, found that survival rates were the same regardless of whether the eye was removed or the patient had instead undergone radiation therapy. Ohio State University is one of more than 40 centers throughout the United States and Canada participating in the study.

Traditionally, physicians have removed the affected eye in patients with this disease, said Frederick Davidorf, a professor of ophthalmology at Ohio State and a principal investigator with the COMS.

The study looked at 1,317 patients with choroidal melanoma -- or cancer of the choroid, the thin layer of vessels beneath the retina. The choroid contains most of the eye's melanocytes, cells that produce and contain pigment. The patients all had medium-sized tumors (2.5 to 10 mm in height and no more than 16 mm in diameter) - ranging from the size of a small pea to a lima bean. Removal of the eye is still the only option for patients with larger tumors, Davidorf said.

Half of the patients (657) underwent radiation therapy, while the other half (660) had their affected eye removed. Findings show that 82 percent of the former group and 81 percent of the latter group were living five years after initial treatment. Also, there was no evidence that either treatment caused harm to the unaffected eye, Davidorf said.

"This is a better-than-expected survival rate, based on information from previous studies of fewer patients," Davidorf said. "We had only expected a 70 percent five-year survival rate when we began the study 16 years ago."

Of the patients who underwent radiation therapy, 63 percent had visual acuity of 20/200 or worse in the treated eye. By five years after treatment, 12 percent had had the treated eye removed due to complications of the radiation treatment or tumor growth. The Ohio State researchers will continue to follow each patient for at least 15 years from initial treatment.

According to the National Eye Institute, between 1,600 and 2,400 new cases of ocular melanoma are diagnosed each year in the United States and Canada.

For more than a century, removal of the eye was the standard treatment for choroidal melanoma, regardless of tumor size.

"The results of this study will save many future patients the physical and mental trauma associated with the loss of an eye," Davidorf said.

Ohio State researchers began looking at radiation as an alternate therapy for choroidal melanoma as early as the late 1960s. A study co-authored by Davidorf in the January 1970 Archives of Ophthalmology found that four out of five patients with choroidal melanoma were successfully treated with radiation.

Eye care professionals typically detect melanoma by dilating a patient's pupil.

The COMS was funded by the National Eye Institute and the National Cancer Institute, which are both part of the National Institutes of Health.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Vision-Saving Treatment Effective For Patients With Eye Cancer." ScienceDaily. ScienceDaily, 17 July 2001. <www.sciencedaily.com/releases/2001/07/010717080358.htm>.
Ohio State University. (2001, July 17). Vision-Saving Treatment Effective For Patients With Eye Cancer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2001/07/010717080358.htm
Ohio State University. "Vision-Saving Treatment Effective For Patients With Eye Cancer." ScienceDaily. www.sciencedaily.com/releases/2001/07/010717080358.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins